Effect of eribulin on patients with metastatic breast cancer: multicenter retrospective observational study in Taiwan
ConclusionsEribulin appears to have better efficacy and cause fewer adverse events, especially neutropenia, in Taiwanese women than Western women.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Hormones | Study | Taiwan Health | Toxicology | Women